Sutro Biopharma Inc’s recently made public that its CHIEF PORT. STRAT & ALNCE OFCR Vasquez Nicki unloaded Company’s shares for reported $60925.0 on Jan 29 ’24. In the deal valued at $5.00 per share,12,185 shares were sold. As a result of this transaction, Vasquez Nicki now holds 12,803 shares worth roughly $60686.22.
Then, Shtylla Brunilda sold 15,428 shares, generating $72,595 in total proceeds. Upon selling the shares at $4.71, the Chief Business Officer now owns 0 shares.
Before that, Shtylla Brunilda sold 11,613 shares. Sutro Biopharma Inc shares valued at $53,282 were divested by the Chief Business Officer at a price of $4.59 per share. As a result of the transaction, Shtylla Brunilda now holds 12,928 shares, worth roughly $61278.72.
Deutsche Bank initiated its Sutro Biopharma Inc [STRO] rating to a Buy in a research note published on November 09, 2023; the price target was $12. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating. Wells Fargo also remained covering STRO and has decreased its forecast on March 21, 2023 with a “an Equal weight” recommendation from previously “an Overweight” rating.
Price Performance Review of STRO
On Monday, Sutro Biopharma Inc [NASDAQ:STRO] saw its stock fall -2.87% to $4.74. Over the last five days, the stock has lost -10.99%. Sutro Biopharma Inc shares have risen nearly 10.49% since the year began. Nevertheless, the stocks have risen 9.47% over the past one year. While a 52-week high of $6.13 was reached on 03/28/24, a 52-week low of $2.01 was recorded on 03/20/24. SMA at 50 days reached $4.56, while 200 days put it at $4.04. A total of 1.17 million shares were traded, compared to the trading of 2.58 million shares in the previous session.
Levels Of Support And Resistance For STRO Stock
The 24-hour chart illustrates a support level at 4.55, which if violated will result in even more drops to 4.37. On the upside, there is a resistance level at 5.10. A further resistance level may holdings at 5.46. The Relative Strength Index (RSI) on the 14-day chart is 52.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.44%. Stochastics %K at 56.20% indicates the stock is a holding.
How much short interest is there in Sutro Biopharma Inc?
A steep rise in short interest was recorded in Sutro Biopharma Inc stocks on Mar 15, 2024, dropping by -0.35 million shares to a total of 2.32 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 2.67 million shares. There was a decline of -15.09%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 3.85% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.68.
The most recent change occurred on June 18, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.
